Concord Biotech (BOM:543960) EPS (Basic) : ₹29.45 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech EPS (Basic)?

Concord Biotech's basic earnings per share (Basic EPS) for the six months ended in Mar. 2024 was ₹16.50. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹29.45.

Concord Biotech's EPS (Diluted) for the six months ended in Mar. 2024 was ₹16.50. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹29.45.

Concord Biotech's EPS without NRI for the six months ended in Mar. 2024 was ₹16.50. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 29.45.

During the past 12 months, Concord Biotech's average EPS without NRIGrowth Rate was 28.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Concord Biotech's highest 3-Year average EPS without NRI Growth Rate was 14.60% per year. The lowest was 10.20% per year. And the median was 12.40% per year.

Concord Biotech EPS (Basic) Historical Data

The historical data trend for Concord Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech EPS (Basic) Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

16.17

22.45

16.72

22.95

29.45

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
EPS (Basic)	Get a 7-Day Free Trial			16.72	6.81	16.14	12.95	16.50

Concord Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Concord Biotech's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3081.032	-	0)	/	104.619
	=	29.45

Concord Biotech's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1725.89	-	0)	/	104.619
	=	16.50

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹29.45

Concord Biotech (BOM:543960) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Concord Biotech EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Concord Biotech's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines